JPRN-jRCT2080221294UnknownPhase 2
A phase 2 dose exploratory study of K-877
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
- Kowa Co., Ltd.
- Enrollment
- 192
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 75age old (—)
- Sex
- All
Inclusion Criteria
- •Dyslipidemia with high TG and low HDL-C
Exclusion Criteria
- •The subject who need to be taken any other anti lipidemic agent
Investigators
Similar Trials
Unknown
Phase 1
Clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222359Kowa Co., Ltd.32
Unknown
Phase 1
clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222360Kowa Co., Ltd.24
Unknown
Phase 3
Dose-finding study of K-877 in combination with pitavastatiDyslipidemiaJPRN-jRCT2080221795Kowa Co., Ltd.168
Unknown
Phase 2
A dose finding study of KRN125Chemotherapy-induced neutropeniaJPRN-jRCT2080220922Kyowa Hakko Kirin Co., Ltd.
Unknown
Phase 1
Phase 1 study of KHK7580JPRN-jRCT2080222486Kyowa Hakko Kirin Co., Ltd.8
